Skip to main content
FinSpry Logo
FinSpry
AUPH logo
AUPH
(NASDAQ)
Aurinia Pharmaceuticals Inc.
$16.25-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Aurinia Pharmaceuticals Inc. (AUPH) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Aurinia Pharmaceuticals Inc. stock.

Analyst Consensus Rating

Investment consensus from 5 professional research analysts

Consensus Rating

Buy
Based on 5 unique analysts
Medium Confidence4.0:1 Buy/Sell

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest AUPH Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

US_Bull
StockTwits
BuyInitiates Coverage
-
Perkun
StockTwits
BuyInitiates Coverage
-
Zacks Equity Research
Zacks Equity Research
SellInitiates Coverage
-
bentley99
StockTwits
BuyInitiates Coverage
-
Auphiliate
StockTwits
BuyInitiates Coverage
-

Frequently Asked Questions

What is the analyst consensus rating for AUPH?

The analyst consensus rating for AUPH is "Buy" based on 5 analyst recommendations.

What is the average price target for AUPH?

The average 12-month price target for AUPH is $not available.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.